NOMAD: unannounced meals on open-source vs commercial AID
What this study tests
A not-yet-recruiting randomized crossover study comparing open-source AID (Loop, AndroidAPS or OpenAPS) with commercial AID (Control-IQ or Omnipod 5) during standardized unannounced meals in adults already using open-source AID.
Editorial review: .
Registry checked: 2026-09-17. Registry’s own update: 2026-08-11.
Most recent recorded citation date: 2026-08-11. Only explicit date metadata is included; an undated citation may be newer. This does not mean every claim was reviewed on that date.
Trial status, labels and access can change between reviews. How we review the evidence · How to read the evidence
Evidence at a glance
- Who can enter the study?
- Adults in Canada or the US with T1D for at least one year who have used open-source AID with Dexcom G6 or G7 for at least two weeks. Registered eligibility ↗Enrollment criteria describe who may enter. They do not establish who was analyzed or the denominator for a reported result.
- Reported benefit and results
- No results. Not yet recruiting; estimated n=33; estimated start 1 October 2026. First posted 11 August 2026.Read the result sources and their limitations →
- Important harms
- Read the reported results, safety discussion and original sources. A separate harms summary is not available; this does not establish safety.
- Research access and approval
- Study regions: Canada. A trial listing does not establish product approval or current recruitment at a particular site. Check the study’s current entry requirements.
- What remains uncertain?
- Read the full discussion and original sources for study limitations. Planned endpoints and completion dates are not results.
Research status alone does not establish approval, clinical benefit or local availability.
Primary endpoints
- Percentage time in 70–180 mg/dL (3.9–10.0 mmol/L) during the 4 hours after standardized unannounced meals
The full picture
NOMAD asks a practical question: when meals are not announced, does an experienced open-source loop hold post-meal glucose as well as Control-IQ or Omnipod 5? It is not a pivotal of a new pump. Until it starts, it is a registered design, not a result.
Sources
- [1]NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) Systems (NOMAD) · Trial registry · 2026-08-11